Amphetamines in the Treatment of Attention-Deficit/Hyperactivity
Amphetamines in the Treatment of Attention-Deficit/Hyperactivity
This is the second in a series of articles in Pediatric Pharmacotherapy focusing on new pharmacologic approaches to the treatment of attention-deficit/hyperactivity disorder (ADHD). This issue will describe the use of the amphetamine products in ADHD, the second most frequently prescribed agents for this disorder, and highlight the new extended release product which offers the convenience of once-daily dosing,
These reviews have been developed for a workshop on therapies for behavioral illnesses in children to be given at the 22 Annual University of Virginia McLemore Birdsong Pediatric Conference from May 17 through 19. For more information, please contact Shirley P. Newman, Conference Coordinator at 434-924-2554.
This is the second in a series of articles in Pediatric Pharmacotherapy focusing on new pharmacologic approaches to the treatment of attention-deficit/hyperactivity disorder (ADHD). This issue will describe the use of the amphetamine products in ADHD, the second most frequently prescribed agents for this disorder, and highlight the new extended release product which offers the convenience of once-daily dosing,
These reviews have been developed for a workshop on therapies for behavioral illnesses in children to be given at the 22 Annual University of Virginia McLemore Birdsong Pediatric Conference from May 17 through 19. For more information, please contact Shirley P. Newman, Conference Coordinator at 434-924-2554.
